Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Setter, Deborah O.a; b; * | Haulcomb, Melissa M.a; b | Beahrs, Taylorc; d | Meadows, Rena M.a; b | Schartz, Nicole D.a; b | Custer, Sara K.a | Sanders, Virginia M.e | Jones, Kathryn J.a; b
Affiliations: [a] Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA | [b] Research and Development, Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA | [c] Department of Cell Biology, Neurobiology, and Anatomy, Loyola University Medical Center, Maywood, IL, USA | [d] Research and Development, Hines VA Hospital, Hines, IL, USA | [e] Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA
Correspondence: [*] Corresponding author: Dr. Deborah O. Setter, Department of Anatomy and Cell Biology, Indiana University School of Medicine, 320 W 15th St NB211C, Indianapolis, IN 46202, USA. Tel.: +1 317 278 2463; E-mail: [email protected].
Abstract: Background:When nerve transection is performed on adult rodents, a substantial population of neurons survives short-term disconnection from target, and the immune system supports this neuronal survival, however long-term survival remains unknown. Understanding the effects of permanent axotomy on cell body survival is important as target disconnection is the first pathological occurrence in fatal motoneuron diseases such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). Objective:The goal of this study was to determine if facial motoneurons (FMN) could survive permanent target disconnection up to 26 weeks post-operation (wpo) after facial nerve axotomy (FNA). In addition, the potentially additive effects of immunodeficiency and motoneuron disease on post-axotomy FMN survival were examined. Methods:This study included three wild type (WT) mouse strains (C57BL/6J, B6SJL, and FVB/NJ) and three experimental models (RAG-2–/–: immunodeficiency; mSOD1: ALS; Smn–/–/SMN2+/+: SMA). All animals received a unilateral FNA, and FMN survival was quantified at early and extended post-operative timepoints. Results:In the C57BL/6J WT group, FMN survival significantly decreased at 10 wpo (55±6%), and then remained stable out to 26 wpo (47±6%). In the RAG-2–/– and mSOD1 groups, FMN death occurred much earlier at 4 wpo, and survival plateaued at approximately 50% at 10 wpo. The SMA model and other WT strains also exhibited approximately 50% FMN survival after FNA. Conclusion:These results indicate that immunodeficiency and motoneuron disease accelerate axotomy-induced neuron death, but do not increase total neuron death in the context of permanent target disconnection. This consistent finding of a target disconnection-resilient motoneuron population is prevalent in other peripheral nerve injury models and in neurodegenerative disease models as well. Characterization of the distinct populations of vulnerable and resilient motoneurons may reveal new therapeutic approaches for injury and disease.
Keywords: Motoneuron, axotomy, amyotrophic lateral sclerosis, spinal muscular atrophy, neuron survival, peripheral nerve injury, motor neuron
DOI: 10.3233/RNN-170809
Journal: Restorative Neurology and Neuroscience, vol. 36, no. 3, pp. 417-422, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]